These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3289210)
1. Current concepts of autoimmune disease. Rose NR Transplant Proc; 1988 Jun; 20(3 Suppl 4):3-10. PubMed ID: 3289210 [TBL] [Abstract][Full Text] [Related]
2. How the immune system achieves self-nonself discrimination during adaptive immunity. Jiang H; Chess L Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320 [TBL] [Abstract][Full Text] [Related]
3. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses. Chen W; Ford MS; Young KJ; Zhang L Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891 [TBL] [Abstract][Full Text] [Related]
4. The syngeneic T-T lymphocyte reaction (STTLR). I. Induction of primary T anti-T cell proliferative responses in T cell cultures stimulated with self- and antigen-reactive T cells. Suzuki H; Evavold B; Swartz TJ; Latta SL; Quintáns J J Mol Cell Immunol; 1986; 2(6):331-44. PubMed ID: 3509918 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells. Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077 [TBL] [Abstract][Full Text] [Related]
6. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells. Suzuki H; Quintáns J J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919 [TBL] [Abstract][Full Text] [Related]
7. Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance. Lou YH; McElveen MF; Garza KM; Tung KS J Immunol; 1996 May; 156(9):3535-40. PubMed ID: 8617983 [TBL] [Abstract][Full Text] [Related]
8. B cells as antigen presenting cells. Rodríguez-Pinto D Cell Immunol; 2005 Dec; 238(2):67-75. PubMed ID: 16574086 [TBL] [Abstract][Full Text] [Related]
9. The role of peripheral T-cell deletion in transplantation tolerance. Wells AD; Li XC; Strom TB; Turka LA Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):617-23. PubMed ID: 11375065 [TBL] [Abstract][Full Text] [Related]
10. A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse. Robe AJ; Kirby JA; Jones DE; Palmer JM Hepatology; 2005 May; 41(5):1106-12. PubMed ID: 15830397 [TBL] [Abstract][Full Text] [Related]
11. [Immunologic tolerance]. Hengartner H Schweiz Rundsch Med Prax; 1989 Jun; 78(26):735-40. PubMed ID: 2526964 [TBL] [Abstract][Full Text] [Related]
12. Breaking of B cell tolerance toward a highly conserved self protein. Dalum I; Jensen MR; Hindersson P; Elsner HI; Mouritsen S J Immunol; 1996 Dec; 157(11):4796-804. PubMed ID: 8943381 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab. Majlessi L; Bordenave G Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234 [TBL] [Abstract][Full Text] [Related]
14. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
15. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. Mamula MJ; Fatenejad S; Craft J J Immunol; 1994 Feb; 152(3):1453-61. PubMed ID: 8301145 [TBL] [Abstract][Full Text] [Related]
16. Selection of thymocyte MHC restriction specificity in vitro. Rock KL; Yeh ET; Benacerraf B J Mol Cell Immunol; 1984; 1(5):311-20. PubMed ID: 6242861 [TBL] [Abstract][Full Text] [Related]
17. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases]. Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605 [TBL] [Abstract][Full Text] [Related]
18. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916 [TBL] [Abstract][Full Text] [Related]
19. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC. Sugihara S; Fujiwara H; Niimi H; Shearer GM J Immunol; 1995 Aug; 155(3):1619-28. PubMed ID: 7543527 [TBL] [Abstract][Full Text] [Related]
20. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions. Milich DR; Louie RE; Chisari FV J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]